Some interesting facts coming out of this or at least nicely documented and not sure if has been mentioned previously.
The white paper with the USyd business school looks like a good off-sided benefit for all cannabis companies in Australia, giving a value to potential medical cannabis market in Australia and provides a good talking point for the industry as a whole.
The assets liabilities ratio is looking good with $8million in cash with loss previous year of $6million so we have a decent amount of money to stretch us through the next financial year. That coupled with expected revenue from the derma product lines
"The Californian distribution deal’s first-year contract is worth approximately €1.2m and the Company expects further revenue uplift in the year ahead."
- Forums
- ASX - By Stock
- RGT
- Ann: Appendix 4E and Audited 2016 Financial Report-MXC.AX
Ann: Appendix 4E and Audited 2016 Financial Report-MXC.AX, page-2
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGT (ASX) to my watchlist
|
|||||
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.31M |
Open | High | Low | Value | Volume |
29.0¢ | 29.0¢ | 29.0¢ | $22 | 75 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 6566 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.5¢ | 44617 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 6566 | 0.290 |
2 | 20000 | 0.270 |
1 | 4000 | 0.250 |
1 | 46516 | 0.215 |
1 | 20000 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.305 | 44617 | 1 |
0.315 | 2825 | 2 |
0.340 | 2358 | 3 |
0.370 | 1056 | 1 |
0.390 | 3420 | 1 |
Last trade - 12.25pm 05/07/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |